MAPS Dare to Dream Big: MDMA Therapy by 2021

herbavore

Bluelight Crew
Joined
Jul 26, 2011
Messages
14,943
MAPS is undertaking a roughly $25 million plan to make MDMA into a Food and Drug Administration (FDA)-approved prescription medicine by 2021, and is currently the only organization in the world funding clinical trials of MDMA-assisted psychotherapy. For-profit pharmaceutical companies are not interested in developing MDMA into a medicine because the patent for MDMA has expired. The idea of using MDMA to assist psychotherapy of any kind for any specific clinical indication has long been in the public domain.

Imagine a world where survivors of childhood abuse, survivors of combat and other war related trauma, survivors of past debilitating traumatic experiences of any kind that rule their present lives, would have access to therapy that uses MDMA as a tool for healing.
 
Top